Finding Predictors of Azathioprine-Induced Pancreatitis in Patients With Inflammatory Bowel Disease.
Marta FreitasTiago Lima CapelaVítor Macedo SilvaCátia ArieiraTiago Cúrdia GonçalvesFrancisca Dias de CastroMaria João MoreiraJoão Firmino-MachadoJosé CotterPublished in: Pancreas (2022)
Although AIP was a relatively common adverse effect, it presented a mild course in all patients. Smoking, concomitant use of budesonide, and single-dose regimen of AZA should be avoided in IBD patients treated with AZA.